Annual Report and Accounts

RNS Number : 8920X

Immupharma PLC

30 June 2008

 



For Immediate Release

30 June 2008

ImmuPharma PLC

Annual Report and Accounts

In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2007, has been posted to shareholders. 

The annual report is available, in electronic form, for download on the Company's website www.immupharma.com. 

For further information please contact: 

ImmuPharma PLC:
Dimitri Dimitriou, Chief Executive Officer	[phone]
Richard Warr, Chairman	[phone]
Buchanan Communications	+ 44 20 7466 5000
Lisa Baderoon
Rebecca Skye Dietrich
Panmure Gordon & Co
Andrew Burnett	[phone]

 

END

 

 

ACSFMMJTMMIJBAP